The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.06
Bid: 14.90
Ask: 15.02
Change: 0.00 (0.00%)
Spread: 0.12 (0.805%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 15.06
ENQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

OPERATIONAL UPDATE

4 Feb 2013 07:00

RNS Number : 0123X
EnQuest PLC
04 February 2013
 



EnQuest PLC, 04 February 2013.

OPERATIONAL UPDATE

 

In relation to EnQuest's current 2022 5.5% bond issue EnQuest will shortly publish a supplementary prospectus, incorporating certain corrections. In addition, EnQuest today provides the following operational update, which is anticipated to be reflected in the supplementary prospectus in due course.

 

Production Summary

 

EnQuest had another good operational performance during 2012, with average daily production of 22,802 Boepd, which compares with the guidance range of average production of 20,000 to 24,000 Boepd and reflected good year end production performances from all of EnQuest's fields.

 

Alma/Galia and Thistle Field Approvals

 

EnQuest's Board has approved an increase in the scope and specification of the Alma/Galia project with the objective of extending the field life, optimising operating costs and enabling a potential second phase development. These changes, which are subject to the normal partner approval process, are expected to extend the FPSO vessel life materially (up to 15 years), and to add additional wells in any second development phase. With the extended field life, the gross field 2P reserves are increased from 29 MMBoe to 34 MMBoe as audited by Gaffney Cline for the existing first phase of development which excludes possible incremental 2C resources for a second phase. Results of all wells drilled to date have been at or better than prognosis. EnQuest will review effects of the well results on reserves, after all wells are completed and analysed.

 

These improvements in adding swivel capacity and extending vessel and project life are expected to increase the gross capital expenditure for the project by approximately $200m. This includes $100m of costs relating to compliance with recent UKCS marine code changes which require upgrades to the mooring system and strengthening of the swivel and vessel hull. In addition, ongoing operations have been impacted by weather related and other cost factors which have resulted in an increase of approximately $100m to the previous capital expenditure estimates. The gross capital expenditure for the Alma/Galia project, in which EnQuest has a 65% working interest, is now expected to total $1.2bn, plus $0.1bn in contingency and growth allowances.

 

In spite of the capital cost increases, the benefits of the extended life related reserves increase and operational improvements to the project will have a positive net present value impact on EnQuest in the first phase of the development. The improvements also create increased potential for additional reserves and value in a potential second phase.

 

EnQuest's Board has also approved the sanctioning of the next phase of the Thistle late life extension project, facilitated as it has been by its qualification for the Brown Field Allowances programme announced by the Government late in 2012.

 

Amjad Bseisu, Chief Executive, said

"It is good to be able to report average production of 22,802 Boepd for 2012, above the middle of the range of our guidance, which is a testament to the success of our drilling programme and good reservoir management.

 

First oil for the Alma/Galia project is still anticipated for Q4 2013. The first phase of the project is now expected to generate significantly greater returns than those foreseen at the time of sanction. The further increase to 34 MMboe in gross 2P reserves for Alma/Galia represents a more attractive first phase development and, with the newly sanctioned improvements, more potential reserves with a second phase."

 

 

ENDS

 

For further information please contact:

 

EnQuest PLC Tel: +44 (0)20 7925 4900

Michael Waring (Head of Communications & Investor Relations)

 

RLM Finsbury Tel: +44 (0)20 7251 3801

James Murgatroyd

Conor McClafferty

Dorothy Burwell

 

Notes to editors

EnQuest is the largest UK independent producer of oil in the UK North Sea. EnQuest trades on both the London Stock Exchange and the NASDAQ OMX Stockholm. It is a constituent of the FTSE 250 index. Its assets include the Thistle, Deveron, Heather, Broom, West Don, Don Southwest and Conrie producing fields and the Alma and Galia development. At the end of June 2012, EnQuest had working interests in 29 production licences covering 36 blocks or part blocks in the UKCS, of which 22 licences are operated by EnQuest.

 

Forward looking statements: This announcement may contain certain forward-looking statements with respect to EnQuest's expectation and plans, strategy, management's objectives, future performance, reserves, production, costs, revenues and other trend information. These statements and forecasts involve risk and uncertainty because they relate to events and depend upon circumstances that may occur in the future. There are a number of factors which could cause actual results or developments to differ materially from those expressed or implied by these forward looking statements and forecasts. The statements have been made with reference to forecast price changes, economic conditions and the current regulatory environment. Nothing in this presentation should be construed as a profit forecast. Past share performance cannot be relied on as a guide to future performance.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAKALEDPDEEF
Date   Source Headline
25th Feb 20217:00 amRNSEagle discovery farm-down
23rd Feb 202111:41 amRNSHolding(s) in Company
22nd Feb 20219:00 amRNSHolding(s) in Company
19th Feb 20213:21 pmRNSHolding(s) in Company
18th Feb 20213:09 pmRNSAdmission to trading
18th Feb 20219:00 amRNSHolding(s) in Company
9th Feb 202110:00 amRNSHolding(s) in Company
5th Feb 20212:49 pmRNSHolding(s) in Company
4th Feb 20215:52 pmRNSHolding(s) in Company
4th Feb 20217:00 amRNSOperations update
4th Feb 20217:00 amRNSAgreement to acquire UKNS asset
3rd Feb 20212:45 pmRNSHolding(s) in Company
3rd Feb 20218:30 amRNSDirectorate Change
29th Jan 20219:12 amRNSBond PIK Announcement
21st Jan 20217:00 amRNSAcquisition
11th Jan 20212:12 pmRNSDirector/PDMR Shareholding
10th Dec 20207:00 amRNSDirectorate Change
24th Nov 20207:00 amRNSOperations update
23rd Oct 20208:56 amRNSBoard Appointment
15th Oct 20209:19 amRNSMaturity date extension: High Yield & Retail Notes
17th Sep 202010:07 amRNSDirector/PDMR Shareholding
14th Sep 20209:22 amRNSDirector/PDMR Shareholding
3rd Sep 20207:00 amRNSEnQuest PLC Half Year Results 2020
20th Aug 202011:14 amRNSAdmission to Trading
31st Jul 20207:00 amRNSEnQuest signs sale and purchase agreement
30th Jul 202010:37 amRNSBond PIK Announcement
29th Jun 20202:11 pmRNSPayments to governments
9th Jun 202012:20 pmRNSDirector/PDMR Shareholding
21st May 20204:20 pmRNSAGM Statement
21st May 20207:00 amRNSOperations update
4th May 202010:22 amRNSDirector/PDMR Shareholding
1st May 20204:26 pmRNSHolding(s) in Company
27th Apr 202010:52 amRNSDirector/PDMR Shareholding
24th Apr 20209:23 amRNSDirector/PDMR Shareholding
23rd Apr 20204:06 pmRNSNotice of AGM and Report & Accounts
21st Apr 202010:31 amRNSDirector/PDMR Shareholding
20th Apr 20203:25 pmRNSDirector/PDMR Shareholding
20th Apr 20202:55 pmRNSHolding(s) in Company
9th Apr 20207:00 amRNSEnQuest 2019 Full Year Results
8th Apr 20208:00 amRNSNotification of full year results announcement
2nd Apr 20201:42 pmRNSDirector/PDMR Shareholding
25th Mar 20202:57 pmRNSFull year results update
19th Mar 20204:16 pmRNSDirectorate Change
19th Mar 20207:00 amRNSOperations update
20th Feb 20203:58 pmRNSAdmission to Trading
4th Feb 20207:00 amRNSOperations update
31st Jan 202011:59 amRNSBond PIK Announcement
6th Jan 202012:14 pmRNSTotal Voting Rights
9th Dec 201910:39 amRNSDirector/PDMR Shareholding
4th Dec 201912:48 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.